National Institute of Drug Abuse
7
3
4
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
14%
1 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Nutrition for Precision Health, Powered by the All of Us
Role: collaborator
Semaglutide Therapy for Alcohol Reduction - Tulsa
Role: collaborator
A Pilot Clinical Trial to Determine the Feasibility of Administering an Electronic Tool to Assess Postoperative pAin, Nausea, and Vomiting in English or Spanish-Speaking Pediatric Patients With Neoplastic Conditions.
Role: collaborator
Peer Recovery Support Services for Individuals in Recovery Residences on MOUD
Role: collaborator
Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
Role: collaborator
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
Role: collaborator
Medication-assisted Treatment for Injecting Drug Users in Vietnam
Role: collaborator
All 7 trials loaded